Activatable photosensitizers for imaging and therapy.
By J. Lovell, T. W. Liu, Juan Chen, G. Zheng. Chemical Reviews, 2010
1,490 citations recorded by the source corpus.
Subfields: Biomedical Engineering, Materials Chemistry, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/19344a4161b0534a5eb9667d2de5fdfd10b52e53
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomedical Engineering
- W. Chan
- Lihong V. Wang
- Vasilis Ntziachristos
- Paul C. Beard
- Peter Kuchment
- Leonid A. Kunyansky
- Markus Haltmeier
- Frederic Lesage
In Materials Chemistry
In Pulmonary and Respiratory Medicine
Citations in the corpus
- Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433 (2018, neutral): “Photodynamic molecular beacons 23 and other photosensitizers that can be enzyme-activated (by tumor-associated proteases, for example) 24 are particularly elegant examples of active targeting, with additional selectivity for malignant tissue built into the design.”
- Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions (2017, background): “As with the therapeutic properties of PSs, diagnostic efficiency can be improved with increased selectivity for tumor cells by either adding targeting mechanisms or localized, cell specific activation of the PS [348].”
- Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. (2011, background): “This is much greater than typical porphyrin quenchin”
- The Smart Drug Delivery System and Its Clinical Potential (2016, background): “TKNs were formulated by poly- (1,4-phenyleneacetone dimethylene thioketal) (PPADT), which was able to degrade selectively in response to ROS.”